Stereotactic body radiation therapy for low- and low-intermediate risk prostate cancer: Is there a dose effect?

This study examines the efficacy and toxicity of two stereotactic body radiation therapy (SBRT) dose regimens for treatment of early prostate cancer. Forty-one patients treated with 35 Gy were matched with 41 patients treated with 36.25 Gy. Both patient groups received SBRT in 5 fractions over 5 co...

Full description

Bibliographic Details
Main Authors: Alan Jay Katz, Richard eAshley, Michael eSantoro, Ferdinand eDiblasio
Format: Article
Language:English
Published: Frontiers Media S.A. 2011-12-01
Series:Frontiers in Oncology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fonc.2011.00049/full